1. Home
  2. MNDR vs SNGX Comparison

MNDR vs SNGX Comparison

Compare MNDR & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • SNGX
  • Stock Information
  • Founded
  • MNDR 2016
  • SNGX 1987
  • Country
  • MNDR Singapore
  • SNGX United States
  • Employees
  • MNDR N/A
  • SNGX N/A
  • Industry
  • MNDR
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNDR
  • SNGX Health Care
  • Exchange
  • MNDR Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • MNDR 6.8M
  • SNGX 6.5M
  • IPO Year
  • MNDR 2024
  • SNGX 1987
  • Fundamental
  • Price
  • MNDR $1.31
  • SNGX $1.90
  • Analyst Decision
  • MNDR
  • SNGX
  • Analyst Count
  • MNDR 0
  • SNGX 0
  • Target Price
  • MNDR N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • MNDR 201.0K
  • SNGX 31.6K
  • Earning Date
  • MNDR 05-27-2025
  • SNGX 05-09-2025
  • Dividend Yield
  • MNDR N/A
  • SNGX N/A
  • EPS Growth
  • MNDR N/A
  • SNGX N/A
  • EPS
  • MNDR N/A
  • SNGX N/A
  • Revenue
  • MNDR $13,968,535.00
  • SNGX $2,342.00
  • Revenue This Year
  • MNDR $188,831.77
  • SNGX N/A
  • Revenue Next Year
  • MNDR $76.44
  • SNGX N/A
  • P/E Ratio
  • MNDR N/A
  • SNGX N/A
  • Revenue Growth
  • MNDR 77.38
  • SNGX N/A
  • 52 Week Low
  • MNDR $0.23
  • SNGX $1.68
  • 52 Week High
  • MNDR $2.85
  • SNGX $14.83
  • Technical
  • Relative Strength Index (RSI)
  • MNDR N/A
  • SNGX 41.12
  • Support Level
  • MNDR N/A
  • SNGX $1.83
  • Resistance Level
  • MNDR N/A
  • SNGX $2.00
  • Average True Range (ATR)
  • MNDR 0.00
  • SNGX 0.11
  • MACD
  • MNDR 0.00
  • SNGX -0.00
  • Stochastic Oscillator
  • MNDR 0.00
  • SNGX 17.07

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: